A new Sephadex™-based method for removing microbicidal and cytotoxic residues when testing antiseptics against viruses: Experiments with a human coronavirus as a model

Journal of Virological Methods

Volumn 159, Issue 2, 2009, Pages 217-226

  Geller, Chloé ^a   Fontanay, Stéphane ^a   Finance, Chantal ^a   Duval, Raphaël E ^a  

^a NANCY UNIVERSITÉ   (France)

Author keywords

Antiseptic evaluation; Chlorhexidine; Gel filtration; Hexamidine; Human coronavirus; Sephadex

Indexed keywords

CHLORHEXIDINE; HEXAMIDINE; SEPHADEX; ANTIVIRUS AGENT;

ANTIVIRAL ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CORONAVIRUS; CYTOTOXICITY; EMBRYO; GEL FILTRATION; HUMAN; HUMAN CELL; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; VALIDATION PROCESS; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS TITRATION; DRUG EFFECT; EVALUATION; GEL CHROMATOGRAPHY; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; METHODOLOGY; MICROBIOLOGICAL EXAMINATION;

CORONAVIRUS; HUMAN CORONAVIRUS 229E;

ANTIVIRAL AGENTS; CHROMATOGRAPHY, GEL; CORONAVIRUS; HUMANS; MICROBIAL SENSITIVITY TESTS; SPECIMEN HANDLING;

EID: 67349151304     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.03.023     Document Type: Article

References (50)

1. AFNOR, 2007. Chemical disinfectants and antiseptics-virucidal quantitative suspension test for chemical disinfectants and antiseptics used in human medicine-test method and requirements (phase 2, step 1).
2. ASTM, 2004. Standard test method for neutralization of virucidal agents in virucidal efficacy evaluations.
3. Bernstein D., Schiff G., Echler G., Prince A., Feller M., and Briner W. In vitro virucidal effectiveness of a 0.12%-chlorhexidine gluconate mouthrinse. J. Dent. Res. 69 (1990) 874-876
4. Bonazzi D., Andrisano V., Gatti R., and Cavrini V. Analysis of pharmaceutical creams: a useful approach based on solid-phase extraction (SPE) and UV spectrophotometry. J. Pharm. Biomed. Anal. 13 (1995) 1321-1329
5. Borenfreund E., and Puerner J.A. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol. Lett. 24 (1985) 119-124
6. Bradburne A.F. An investigation of the replication of coronaviruses in suspension cultures of L132 cells. Arch. Gesamte Virusforsch. 37 (1972) 297-307
7. Carret A.S., and Le Faou A. Adénovirus. In: Pozzetto B. (Ed). Les Infections Nosocomiales Virales et à Agents Transmissibles Non Conventionnels. (2001), John Libbey Eurotext, Paris 237-245
8. Drosten C., Gunther S., Preiser W., van der Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A., Berger A., Burguiere A.M., Cinatl J., Eickmann M., Escriou N., Grywna K., Kramme S., Manuguerra J.C., Muller S., Rickerts V., Sturmer M., Vieth S., Klenk H.D., Osterhaus A.D., Schmitz H., and Doerr H.W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348 (2003) 1967-1976
9. Duan S.M., Zhao X.S., Wen R.F., Huang J.J., Pi G.H., Zhang S.X., Han J., Bi S.L., Ruan L., and Dong X.P. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed. Environ. Sci. 16 (2003) 246-255
10. European Pharmacopeia, 2007. Chlorhexidine digluconate (solution of).
11. European Pharmacopeia, 2007. Hexamidine diisethionate.
12. Falsey A.R., Walsh E.E., and Hayden F.G. Rhinovirus and coronavirus infection-associated hospitalizations among older adults. J. Infect. Dis. 185 (2002) 1338-1341
13. Fleurette J. Diamidines aromatiques. In: Fleurette J., Freney J., and Reverdy M.-E. (Eds). Antisepsie et Désinfection. (1995), Edition ESKA, Paris 320-324
14. Gagneur A., Legrand M.C., Picard B., Baron R., Talbot P.J., de Parscau L., and Sizun J. Nosocomial infections due to human coronaviruses in the newborn. Arch. Pediatr. 9 (2002) 61-69
15. Gagneur A., Sizun J., Vallet S., Legr M.C., Picard B., and Talbot P.J. Coronavirus-related nosocomial viral respiratory infections in a neonatal and paediatric intensive care unit: a prospective study. J. Hosp. Infect. 51 (2002) 59-64
16. Graham M.L., Springthorpe V.S., and Sattar S.A. Ex vivo protocol for testing virus survival on human skin: experiments with herpesvirus 2. Appl. Environ. Microbiol. 62 (1996) 4252-4255
17. Ha Y., and Cheung A.P. New stability-indicating high performance liquid chromatography assay and proposed hydrolytic pathways of chlorhexidine. J. Pharm. Biomed. Anal. 14 (1996) 1327-1334
18. Hamre D., and Procknow J.J. A new virus isolated from the human respiratory tract. Proc. Soc. Exp. Biol. Med. 121 (1966) 190-193
19. Havlikova L., Matysova L., Novakova L., Hajkova R., and Solich P. HPLC determination of chlorhexidine gluconate and p-chloroaniline in topical ointment. J. Pharm. Biomed. Anal. 43 (2007) 1169-1173
20. Hebert V.R., Middleton J.R., Tomaszewska E., and Fox L.K. Methodology for quantifying residues of chlorhexidine in raw dairy milk. J. Agric. Food Chem. 51 (2003) 567-570
21. Holmes K.V. Coronaviruses. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. fourth ed. (2001), Lippincott-Raven, Philadelphia 1187-1203
22. Ijaz M.K., Brunner A.H., Sattar S.A., Nair R.C., and Johnson-Lussenburg C.M. Survival characteristics of airborne human coronavirus 229E. J. Gen. Virol. 66 Pt. 12 (1985) 2743-2748
23. Ijaz M.K., and Rubino J. Should test methods for disinfectants use vertebrate viruses dried on carriers to advance virucidal claims?. Infect. Control Hosp. Epidemiol. 29 (2008) 192-194
24. Kawana R., Kitamura T., Nakagomi O., Matsumoto I., Arita M., Yoshihara N., Yanagi K., Yamada A., Morita O., Yoshida Y., Furuya Y., and Chiba S. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology 195 (1997) 29-35
25. Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., Rollin P.E., Dowell S.F., Ling A.E., Humphrey C.D., Shieh W.J., Guarner J., Paddock C.D., Rota P., Fields B., DeRisi J., Yang J.Y., Cox N., Hughes J.M., LeDuc J.W., Bellini W.J., and Anderson L.J. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348 (2003) 1953-1966
26. Larson H.E., Reed S.E., and Tyrrell D.A. Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J. Med. Virol. 5 (1980) 221-229
27. Moes E., Vijgen L., Keyaerts E., Zlateva K., Li S., Maes P., Pyrc K., Berkhout B., van der Hoek L., and Van Ranst M. A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect. Dis. 5 (2005) 6
28. Morinet, F., Pallier, C., Pillet, S., 2003. Parvoviridae. In: Huraux, J.M., Nicolas, J.C., Agut, H., Peigue-Lafeuille, H. (Eds.). Traité de Virologie Médicale, Paris, pp. 283-290.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
30. Narang H.K., and Codd A.A. Action of commonly used disinfectants against enteroviruses. J. Hosp. Infect. 4 (1983) 209-212
31. Nicholson K.G., Kent J., Hammersley V., and Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ 315 (1997) 1060-1064
32. Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., Nicholls J., Yee W.K., Yan W.W., Cheung M.T., Cheng V.C., Chan K.H., Tsang D.N., Yung R.W., Ng T.K., and Yuen K.Y. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361 (2003) 1319-1325
33. Pene F., Merlat A., Vabret A., Rozenberg F., Buzyn A., Dreyfus F., Cariou A., Freymuth F., and Lebon P. Coronavirus 229E-related pneumonia in immunocompromised patients. Clin. Infect. Dis. 37 (2003) 929-932
34. Platt J., and Bucknall R.A. The disinfection of respiratory syncytial virus by isopropanol and a chlorhexidine-detergent handwash. J. Hosp. Infect. 6 (1985) 89-94
35. Rabenau H.F., Cinatl J., Morgenstern B., Bauer G., Preiser W., and Doerr H.W. Stability and inactivation of SARS coronavirus. Med. Microbiol. Immunol. 194 (2005) 1-6
36. Reed L.J., and Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27 (1938) 493-497
37. Sattar S.A., and Ansari S.A. The fingerpad protocol to assess hygienic hand antiseptics against viruses. J. Virol. Methods 103 (2002) 171-181
38. Sattar S.A., Jacobsen H., Springthorpe V.S., Cusack T.M., and Rubino J.R. Chemical disinfection to interrupt transfer of rhinovirus type 14 from environmental surfaces to hands. Appl. Environ. Microbiol. 59 (1993) 1579-1585
39. Sattar S.A., Springthorpe V.S., Adegbunrin O., Zafer A.A., and Busa M. A disc-based quantitative carrier test method to assess the virucidal activity of chemical germicides. J. Virol. Methods 112 (2003) 3-12
40. Sattar S.A., Springthorpe V.S., Karim Y., and Loro P. Chemical disinfection of non-porous inanimate surfaces experimentally contaminated with four human pathogenic viruses. Epidemiol. Infect. 102 (1989) 493-505
41. Sizun J., Yu M.W., and Talbot P.J. Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections. J. Hosp. Infect. 46 (2000) 55-60
42. Sturman L.S., Ricard C.S., and Holmes K.V. Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37 °C correlates with virus aggregation and virus-induced cell fusion. J. Virol. 64 (1990) 3042-3050
43. Tyler R., and Ayliffe G.A. A surface test for virucidal activity of disinfectants: preliminary study with herpes virus. J. Hosp. Infect. 9 (1987) 22-29
44. Vabret A., Dina J., Gouarin S., Petitjean J., Tripey V., Brouard J., and Freymuth F. Human (non-severe acute respiratory syndrome) coronavirus infections in hospitalised children in France. J. Paediatr. Child. Health 44 (2008) 176-181
45. Vabret A., Mourez T., Gouarin S., Petitjean J., and Freymuth F. An outbreak of coronavirus OC43 respiratory infection in Normandy. France. Clin. Infect. Dis. 36 (2003) 985-989
46. Van der Hoek L., Pyrc K., Jebbink M.F., Vermeulen-Oost W., Berkhout R.J., Wolthers K.C., Wertheim-van Dillen P.M., Kaandorp J., Spaargaren J., and Berkhout B. Identification of a new human coronavirus. Nat. Med. 10 (2004) 368-373
47. Van Elden L.J., van Loon A.M., van Alphen F., Hendriksen K.A., Hoepelman A.I., van Kraaij M.G., Oosterheert J.J., Schipper P., Schuurman R., and Nijhuis M. Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction. J. Infect. Dis. 189 (2004) 652-657
48. Winther B., McCue K., Ashe K., Rubino J.R., and Hendley J.O. Environmental contamination with rhinovirus and transfer to fingers of healthy individuals by daily life activity. J. Med. Virol. 79 (2007) 1606-1610
49. Woo P.C., Lau S.K., Chu C.M., Chan K.H., Tsoi H.W., Huang Y., Wong B.H., Poon R.W., Cai J.J., Luk W.K., Poon L.L., Wong S.S., Guan Y., Peiris J.S., and Yuen K.Y. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J. Virol. 79 (2005) 884-895
50. Wood A., and Payne D. The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses. J. Hosp. Infect. 38 (1998) 283-295